424 related articles for article (PubMed ID: 20410852)
21. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation.
Molina BD; Leiro MG; Pulpón LA; Mirabet S; Yañez JF; Bonet LA; Vilchez FG; Delgado JF; Manito N; Rábago G; Arizón JM; Romero N; Roig E; Blasco T; Pascual D; de la Fuente L; Muñiz J
Transplant Proc; 2010 Oct; 42(8):3001-5. PubMed ID: 20970593
[TBL] [Abstract][Full Text] [Related]
23. Skin cancer after pancreas transplantation.
Spanogle JP; Kudva YC; Dierkhising RA; Kremers WK; Roenigk RK; Brewer JD; Prieto M; Otley CC
J Am Acad Dermatol; 2012 Oct; 67(4):563-9. PubMed ID: 22341468
[TBL] [Abstract][Full Text] [Related]
24. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
25. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
26. Biological amplification factor for sunlight-induced nonmelanoma skin cancer at high latitudes.
Moan J; Dahlback A; Henriksen T; Magnus K
Cancer Res; 1989 Sep; 49(18):5207-12. PubMed ID: 2766289
[TBL] [Abstract][Full Text] [Related]
27. Squamous and basal cell carcinoma in heart transplant recipients.
Lampros TD; Cobanoglu A; Parker F; Ratkovec R; Norman DJ; Hershberger R
J Heart Lung Transplant; 1998 Jun; 17(6):586-91. PubMed ID: 9662094
[TBL] [Abstract][Full Text] [Related]
28. Risk factors associated with the development of skin cancer after liver transplantation.
Mithoefer AB; Supran S; Freeman RB
Liver Transpl; 2002 Oct; 8(10):939-44. PubMed ID: 12360438
[TBL] [Abstract][Full Text] [Related]
29. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial.
Pandeya N; Purdie DM; Green A; Williams G
Am J Epidemiol; 2005 Apr; 161(8):748-54. PubMed ID: 15800267
[TBL] [Abstract][Full Text] [Related]
30. Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience.
Buell JF; Hanaway MJ; Thomas M; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):962-3. PubMed ID: 15848591
[TBL] [Abstract][Full Text] [Related]
31. Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer.
Paradisi A; Waterboer T; Sampogna F; Tabolli S; Simoni S; Pawlita M; Abeni D
Br J Dermatol; 2011 Oct; 165(4):782-91. PubMed ID: 21561438
[TBL] [Abstract][Full Text] [Related]
32. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
33. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
McGeown MG; Douglas JF; Middleton D
Clin Transpl; 2000; ():193-202. PubMed ID: 11512313
[TBL] [Abstract][Full Text] [Related]
34. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
[TBL] [Abstract][Full Text] [Related]
35. Skin malignancies in renal transplant recipients: a Brazilian center registry.
Falsarella PM; Alves-Filho G; Mazzali M
Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
[TBL] [Abstract][Full Text] [Related]
36. Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.
Gutiérrez-Dalmau A; Revuelta I; Ferrer B; Mascaró JM; Oppenheimer F; Albanell J; Campistol JM
Transplantation; 2010 Nov; 90(9):986-92. PubMed ID: 20844469
[TBL] [Abstract][Full Text] [Related]
37. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous manifestations in renal transplant recipients of Santiago, Chile.
Sandoval M; Ortiz M; Díaz C; Majerson D; Molgó M
Transplant Proc; 2009 Nov; 41(9):3752-4. PubMed ID: 19917380
[TBL] [Abstract][Full Text] [Related]
39. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
40. Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study.
van der Pols JC; Heinen MM; Hughes MC; Ibiebele TI; Marks GC; Green AC
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1167-73. PubMed ID: 19336544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]